Hematological aspects of Crimean-Congo hemorrhagic fever

Turkish Journal of Hematology

Volumn 26, Issue 4, 2009, Pages 161-166

  Duru, Feride ^a   Fişgin, Tunç ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; Hematological manifestation; Hemophagocytosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIFIBRINOLYTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BLOOD CLOTTING FACTOR 7; CORTICOSTEROID; CREATINE KINASE; CYCLOSPORIN A; DEXAMETHASONE; DROTRECOGIN; ETOPOSIDE; FERRITIN; FIBRINOGEN; GAMMA INTERFERON; HEPARIN; LACTATE DEHYDROGENASE; LOW MOLECULAR WEIGHT HEPARIN; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DETECTION; BLEEDING; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISSEMINATED INTRAVASCULAR CLOTTING; EPIDEMIC; ERYTHROPHAGOCYTOSIS; FEVER; HEADACHE; HEMATOLOGICAL PARAMETERS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HOSPITAL INFECTION; HUMAN; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LYMPHOCYTE ACTIVATION; MACROPHAGE; MONOCYTE; MYALGIA; NAIRO VIRUS; NAUSEA; NONHUMAN; PATHOGENESIS; PROGNOSIS; REVIEW; SPRING; SUMMER; THROMBOCYTE ACTIVATION; THROMBOPLASTIN TIME; TICK BORNE DISEASE; VIRUS HEMORRHAGIC FEVER; VOMITING;

EID: 73649102027     PISSN: 13007777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Ergonul O. Treatment of Crimean Congo hemorrhagic fever. In: Ergonul O, Whitehouse CA, editors. Crimean Congo Hemorrhagic Fever: A Global Perspective. Dordrecht, Netherlands: Springer, 2007: 245-60.
2. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004;64:145-60.
3. Ergönül O, Zeller H, Kiliç S, Kutlu S, Kutlu M, Cavusoglu S, Esen B, Dokuzoǧuz B. Zoonotic infections among veterinarians in Turkey: Crimean-Congo hemorrhagic fever and beyond. Int J.Infect Dis 2006;10:465-9.
4. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo haemorrhagic fever in Asia, Europe and Africa. J Med Entomol 1979;15:307-417.
5. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis 2007;20:495-500.
6. Ergonul O. Crimean-Congo hemorrhagic fever. Lancet Infect Dis 2006;6:203-6.
7. Schwarz TF, Nsanze A, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 1997;40:364-7.
8. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, Torunoglu MA. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey: 2002-2007. Int J Infect Dis 2009;13:380-6.
9. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, Ozkaya S, Ertek M. A preliminary method on Crimean Congo hemorrhagic fever Turkey, March - June 2008. Euro Surveill 2008;13:18953.
10. Turkish Ministry of Health (Internet). Kirim-kongo kanamali ateşi vaka ve ölümlerinin yillara göre daǧilimi. Two pages. [updated 2008] Available from: http://www.saglik.gov.tr/KKKA/BelgeGoster.aspx? F6E10F8892433CFF1A9547B61DAFFE2AAE52736517C4A993
11. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, Tasyaran MA. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006;52:207-15.
12. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, Akdogan E, Eren N, Koksal I, Ovali E, Erickson BR, Vincent MJ, Nichol ST, Comer JA, Rollin PE, Ksiazek TG. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004;10:1379-84.
13. Midilli K, Gargili A, Ergonul O, Sengöz G, Ozturk R, Bakar M, Jongejan F. Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis 2007;7:54.
14. Tasdelen Fisgin N, Tanyel E, Sarikaya H, Cicek B, Doganci L, Tulek N. Kirim Kongo Kanamali ateşi: Endemik bölgedeki üniversite hastanesi deneyimi. Türk Mikrobiyoloji Kongresi, Bodrum, 2008.
15. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 2004;39:284-7.
16. Joubert JR, King JB, Rossouw DJ, Cooper R. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S Afr Med J 1985;68:722-8.
17. Duh D, Saksida A, Petrovec M, Ahmeti S, Dedushaj I, Panning M, Drosten C, Avsic-Zupanc T. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis 2007;13:1769-72.
18. Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med 2007;10:204-14.
19. Tanir G, Tuygun N, Balaban I, Doksöz O. A case of Crimean-Congo hemorrhagic fever with pleural effusion. Jpn J Infect Dis 2009;62:70-2.
20. Doganci L, Ceyhan M, Tasdelen NF, Sarikayalar H, Tulek N. Crimean-Congo hemorrhagic fever and diffuse alveolar hemorrhage. Trop Doct 2008;38:252-4.
21. Engin A, Erdogan H, Ozec AV, Elaldi N, Toker MI, Bakir M, Dokmetas I, Arici MK. Ocular findings in patients with Crimean-Congo hemorrhagic fever. Am J Ophthalmol 2009;147:634-8.
22. Celikbas A, Ergonul O, Dokuzoglu B, Eren S, Baykam N, Polat Duzgun A. Crimean-Congo hemorrhagic fever infection simulating acute appendicitis. J Infect 2005;50:363-5.
23. Cevik AM, Erbay A, Bodur H, Gulderen E, Bastug A, Kubar A, Akinci E. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Inf Dis 2008;12:374-9.
24. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006;12:551-4.
25. Tasdelen Fisgin N, Fisgin T, Tanyel E, Doganci L, Tulek N, Guler N, Duru F. Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome. Am J Hematol 2008;83:73-6.
26. Cagatay A, Kapmaz M, Karadeniz A, Basaran S, Yeneral M, Yavuz S, Midilli K, Ozsut H, Eraksoy H, Calagu S. Hemophagocytosis in a patient with Crimean-Congo hemorrhagic fever. J Med Microbiol 2007;56:1126-8.
27. Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N. Risk factors for fatality in patients with Crimean-Congo hemorrhagic fever. Trop Doct 2009;39:158-60.
28. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1988;11:794-800.
29. Sonmez M, Aydin K, Durmus A, Sucu N, Yilmaz M, Akdogan E, Koksal I, Ovali E, Omay SB. Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever. J Infect 2007;55:379-81.
30. Yilmaz M, Aydin K, Akdogan E, Sucu N, Sonmez M, Omay SB, Koksal I. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J Clin Virol 2008;42:415-7.
31. Akinci E, Yilmaz M, Bodur H, Ongürü P, Bayazit FN, Erbay A, Ozet G. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever. Int J Infect Dis 2009;13(5):560-3.
32. Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005:82-88.
33. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004;3:69-75.
34. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S, Tawa A. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997;89:4100-3.
35. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 2006;36:272-6.
36. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B.. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006;193:941-4.
37. Sannikova IV, Pacechnikov VD, Maleev VV. Respiratory lesions in Congo-Crimean hemorrhagic fever. Ter Arkh 2007;79:20-3.
38. Weber F, Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zoonosis. Cytokine Growth Factor Rev 2008;19:395-404.
39. Ongoru P, Akgul EO, Akinci E, Yaman H, Kurt YG, Erbay A, Beyazit FN, Bodur H, Erbil K, Acikel CH, Cevik MA. High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Inf 2008;56:366-70.
40. Takada H, Nomura A, Ohga S, Hara T. Interleukin-18 in hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2001;42:21-8.
41. Maeno N, Takei S, Imanaka H, et al. Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome. Arthritis Rheum 2004;50:1935-58.
42. Henter IJ, Horne AC, Maurizio A, Egeler RM, Filipovich AH, Imashuku S, Ladish S, MClein K, Webb D, Winiarski J, Gritta J. HHL-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
43. Güngör O, Kayacik O, Guven A, Kalayci AG, Duru F. Çocuklarda Kirim Kongo Kanamali Ateşi hastaliǧi.50. Turkish National Pediatric Congress.8-12 Kasim 2006. Antalya.
44. Larichev VF, Manzeniuk IN, Naǐdenova EV, Karan' LS, Sharova IN, Shcherbakova SA, Khutoretskaia NV, Skorokhod MA, Kulichenko AN, Vorob'eva MS, Platonov AE, Butenko AM. ELISA and PCR test systems used to detect Crimean-Congo hemorrhagic fever virus. Vopr Virusol 2007;52:43-6.
45. Drosten C, Göttig S, Schilling S, Asper M, Panning M, Schmitz H, Günther S. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. Scand J Infect Dis 2007;39:332-6.
46. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral R 2008;78:125-31.
47. Tasdelen Fisgin N, Ergonul O, Doganci L, Tulek N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis 2009;28:929-33.
48. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis 2003;36:1613-8.
49. Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, Leblebicioglu H, Yilmaz N, Engin A, Sencan M, Aydin K, Dokmetas I, Cevik MA, Dokuzoguz B, Tasyaran MA, Ozturk R, Bakir M, Uzun R. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect 2009;58:238-44.
50. Henter JI, Elinder G, Söder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991;78:2918-22.
51. Janka G, Elinder G, Imashuku S. Infection and malignancy associated hemophagocytic syndrome: secondary lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:417-33.
52. Warson HG, Goulden NJ, Manson LM, McDermid, Gray JA. Virus associated hemophagocytic syndrome: further evidence for a T cell mediated disorder. Br J Haematol 1994;86:213-5.
53. Jabbari A, Besharat S, Abbasi A, Moradi A, Kalavi K. Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004). Indian J Med Sci 2006;60:1-4.
54. Oyama Y, Amanci T, Hirakawa S, Hironaka K, Suzuki S, Ota Z. Hemophagocytic syndrome treated with cyclosporin A: a T cell disorder. Br J Haematol 1989;73:276-8.
55. Tsuda H. The use of cyclosporin-A in the treatment of virus associated hemophagocytic syndrome in adults. Leuk Lymphoma 2007;28:73-82.
56. Erduran E, Gedik Y, Sen Y, Yildiran A. Successful treatment of reactive hemophagocytic syndrome with cyclosporine A and intravenous immunoglobulin. Turk J Pediatr 2000;42:168-70.
57. Hatta T, Takenaka M, Shimura K, Yoshizumi M, Sato T, Nakagawa C, Akamatsu N, Nakagaki Y, Yoneda Y, Takada O, Maki K, Sawada K, Fujita N. A case of IAHS (infection associated hemophagocytic syndrome) successfully treated with etoposide. Gan To Kagaku Ryoho 1997;24:2271-5.
58. Ogasawara T, Kawauchi K, Yasayuma M, Ohkawa S. Successful use of etoposide in an elderly patient with recurrent hemophagocytic syndrome. Nippon Ronen Iggagkkai Zasshi 2003;40:160-6.
59. Gurgey A, Secmeer G, Tavil B, Ceyhan M, Kuskonmaz B, Cengiz B, Ozen H, Kara A, Cetin M, Gumruk F. Secondary hemophagocytic lymphohistiocytosis in Turkish children. Ped Inf Dis 2005;24:1116-7.